Diabetes

Latest News


The announced price for alirocumab, the first PCSK9 inhibitor approved for use in the US, was the top story in managed care this week. Also, HHS announced $100 million available to combat substance abuse, and Medicare and Medicaid turn 50 years old.

CMS' shift to value-based payments has also shifted diabetes care models from cost-centered systems to cost-savings centers, according to Robert A. Gabbay, MD, PhD, chief medical officer and senior vice president of Joslin Diabetes Center.

Highlights from the American Diabetes Association's 75th Scientific Sessions, which took place on June 5-9, 2015, in Boston, are available in a newsletter published by The American Journal of Managed Care.